by Elizabeth Kissling | Jun 24, 2010 | Birth Control, Health Care, New Research
Did you know that last year’s combined sales of Yaz and Yasmin, the most popular oral contraceptives in the U.S., totaled $1.64 billion? Did you know the drugs are also the target of 1,100 lawsuits for potentially fatal blood clots? Did you know that an estimated 50...
by Elizabeth Kissling | Jun 23, 2010 | Menopause, New Research, Pharmaceutical
The Endocrine Society has released a new, peer-reviewed statement on the risks and benefits of hormone therapy for menopausal women. The upshot is that risks and benefits vary depending on the age of the patient and the length of time since menopause: One interesting...
by Elizabeth Kissling | Jun 19, 2010 | Internet
This week’s picks: The FDA declines to approve “pink Viagra”, a.k.a. flibanserin, to treat low female sexual desire. For more, check out these materials from the New View Campaign. In other FDA news, the organization’s Advisory Committee for...
by Elizabeth Kissling | Jun 17, 2010 | Health Care, New Research
A new report indicates that surgery for endometriosis performed by a robot is less effective than the same procedure performed by a surgeon. The mechanically assisted procedure also took longer to complete. Performing this surgery the traditional way can also help...
by Elizabeth Kissling | Jun 15, 2010 | Anatomy, Communication, Film, Independent Film, magazines, Media
In Therese Shechter’s guest-post about the German teen magazine feature article, “Every Vulva Is Different”, she noted that we’re unlikely to see such an explicit, body-positive article in a U.S. teen magazine. Therese, as usual, knows what...
